By: Erin Alessandroni
As advances in imaging and other technologies continue to take place, clinicians will have the ability to diagnose Alzheimer’s disease (AD) years before the onset of clinical symptoms. This progress may present difficulties, such as informing cognitively healthy individuals of potentially distressing information.
Kristin Harkins, MPH and Jason Karlawish, MD, both of the Penn Memory Center, provide considerations clinicians must make when disclosing amyloid status to a person without cognitive impairments in an article published to Practical Neurology.